When was LVIS founded?

LVIS was founded in 2011 and raised its 1st funding round 7 years after it was founded.

Where is LVIS located?

LVIS is headquartered in Palo Alto, United States.

How many employees does LVIS have?

As of Oct 31, 2026, the latest employee count at LVIS is 43.

Is LVIS a funded company?

LVIS is a funded company, having raised a total of $18M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2018.

When was the latest funding round of LVIS?

LVIS's latest funding was a $***** Series B round on Jan 10, 2022, with participation from 1 investor.

Where does LVIS rank among its competitors?

LVIS ranks 9th amongst 71 active competitors, of which 29 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Omniscient, which secured $27.2M in May, 2026.

Who are the top competitors of LVIS?

LVIS's top competitors include NEUROPHET, BrainSightAI and RapidAI. Among them, Omniscient secured the most recent funding round in May, 2026.

LVIS - 2026 Company Profile, Team, Funding & Competitors

LVIS is a series B company based in Palo Alto (United States), founded in 2011 by Jin Hyung Lee. It operates as an AI powered EEG analysis platform for neurological disease diagnosis. LVIS has raised $18M in funding from SK Networks and SK. The company has 71 active competitors, including 29 funded and 5 that have exited. Its top competitors include companies like NEUROPHET, BrainSightAI and RapidAI.

Company Details

AI powered EEG analysis platform for neurological disease diagnosis. This platform offers comprehensive results through instant web access to cloud stored diagnostic data, enhancing collaboration and patient care. Key features include artifact reduction, longitudinal patient reports, automated reports, and browser based access with role based controls. The platform adheres to relevant regulatory standards. It also develops neural information analysis technology that decodes brain networks and provides visualizations to assist in neurological disease diagnosis.

Website: lviscorp.com/en/
Email ID: *****@lviscorp.com

Key Metrics

Founded Year

2011

Location

Palo Alto, United States

Stage

Series B

Total Funding

$18M in 2 rounds

Latest Funding Round

Series B, Jan 10, 2022, $*****

Investors

SK Networks & 5 more

Ranked

9^th among 71 active competitors

Employee Count

43 as on Oct 31, 2026

Similar Companies

NEUROPHET & 73 more

View LVIS's full profile

LVIS has raised a total funding of $18M over 2 rounds. Its first funding round was on 2018. Its latest funding round was a Series B round on Jan 10, 2022 for $*****. 1 investor participated in its latest round. LVIS has 6 institutional investors.

Here is the list of recent funding rounds of LVIS:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 10, 2022	8182004	Series B	7065298	4818418	9067728	9507877
2018	9273	Series A	4287	2926	SK	6545

Access funding benchmarks and valuations. Sign up today!

View details of LVIS's funding rounds and investors

The founders of LVIS is Jin Hyung Lee. Dhruva Kumar is the CEO of LVIS.

Here are the details of LVIS's key team members:

Jin Hyung Lee: Founder of LVIS.
Dhruva Kumar: CEO of LVIS.

View details of LVIS's Founder profiles and Board Members

LVIS's employee count trend

LVIS has 43 employees as of Oct 26. Here is LVIS's employee count trend over the years:

Uncover LVIS's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LVIS include NEUROPHET, BrainSightAI and RapidAI. Here is the list of Top 10 competitors of LVIS, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	ES Investor, SBI Investment Korea & 19 others	61/100
2nd	BrainSightAI 2019, Bengaluru (India), Seed	AI based platform offering connectomics for functional brain mapping	$6.86M	Pfizer, Indian Angel Network & 51 others	60/100
3rd	RapidAI 2012, San Mateo (United States), Series C	Developer of clinical AI platform enhancing medical imaging and stroke care	$100M	Lennertz, Vistacreditpartners & 2 others	57/100
4th	Cortechs.ai 2001, San Diego (United States), Series C	Provider of AI-powered medical imaging analysis software	$9.07M	NIH, Europa & 2 others	56/100
5th	Cerebriu 2018, Copenhagen (Denmark), Series A	AI-based imaging software for the diagnosis of brain disease	$29.5M	Innovationsfonden, North Ventures & 9 others	56/100
6th	icometrix 2011, Leuven (Belgium), Acquired	Provider of an AI based software for analysis of brain MRI images	$20.2M	Forestay Capital, Capricorn Partners & 9 others	55/100
7th	Omniscient 2019, Sydney (Australia), Series D	Provider of AI-powered brain mapping and analysis platform	$60M	National Reconstruction Fund, OIF Ventures ... & 5 others	55/100
8th	Methinks 2016, Barcelona (Spain), Seed	Provider of AI and cloud-based software for the diagnosis of strokes	-	EIC Fund, Aei & 4 others	52/100
9th	LVIS 2011, Palo Alto (United States), Series B	AI powered EEG analysis platform for neurological disease diagnosis	$18M	A&E Investments, SK & 4 others	42/100
10th	Braintale 2018, Strasbourg (France), Series A	AI-based brain assessment and disease diagnosis for providers	$6.1M	MACSF, Angels Sante & 6 others	42/100